ES2800327T3 - Composiciones dietéticas y métodos de protección contra la quimioterapia o radioterapia - Google Patents

Composiciones dietéticas y métodos de protección contra la quimioterapia o radioterapia Download PDF

Info

Publication number
ES2800327T3
ES2800327T3 ES09734637T ES09734637T ES2800327T3 ES 2800327 T3 ES2800327 T3 ES 2800327T3 ES 09734637 T ES09734637 T ES 09734637T ES 09734637 T ES09734637 T ES 09734637T ES 2800327 T3 ES2800327 T3 ES 2800327T3
Authority
ES
Spain
Prior art keywords
animal
human
chemotherapy
composition
radiotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09734637T
Other languages
English (en)
Spanish (es)
Inventor
Valter Longo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stevens Center for Innovation of USC
Original Assignee
Stevens Center for Innovation of USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stevens Center for Innovation of USC filed Critical Stevens Center for Innovation of USC
Application granted granted Critical
Publication of ES2800327T3 publication Critical patent/ES2800327T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ES09734637T 2008-04-24 2009-04-24 Composiciones dietéticas y métodos de protección contra la quimioterapia o radioterapia Active ES2800327T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4768008P 2008-04-24 2008-04-24
PCT/US2009/041736 WO2009132320A2 (en) 2008-04-24 2009-04-24 Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging

Publications (1)

Publication Number Publication Date
ES2800327T3 true ES2800327T3 (es) 2020-12-29

Family

ID=41217444

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09734637T Active ES2800327T3 (es) 2008-04-24 2009-04-24 Composiciones dietéticas y métodos de protección contra la quimioterapia o radioterapia

Country Status (5)

Country Link
EP (1) EP2285218B1 (cg-RX-API-DMAC7.html)
JP (2) JP2011523626A (cg-RX-API-DMAC7.html)
CA (2) CA2722365C (cg-RX-API-DMAC7.html)
ES (1) ES2800327T3 (cg-RX-API-DMAC7.html)
WO (1) WO2009132320A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012111790A1 (ja) * 2011-02-17 2012-08-23 味の素株式会社 化学療法剤の抗腫瘍活性増強剤
JP5752980B2 (ja) * 2011-04-04 2015-07-22 日本メジフィジックス株式会社 腎臓トランスポーターの輸送能を抑制するための組成物
CA2900782C (en) * 2013-02-12 2022-09-27 University Of Southern California Methods and diets to protect against chemotoxicity and age related illnesses
CN106456631A (zh) * 2014-03-06 2017-02-22 南加利福尼亚大学 利用短期饥饿方案结合激酶抑制剂来增强传统化学药物功效和可行性并逆转激酶在正常细胞和组织中的副作用
EP3115047B1 (en) * 2014-03-07 2020-05-06 Ajinomoto Co., Inc. Debility preventative
EP3291693A4 (en) * 2015-05-06 2019-04-03 University of Southern California FASTENIMITIER AND IMPROVING DIET FOR THE TREATMENT OF HYPERTENSION AND LIPID DISORDER
CN112752575A (zh) * 2018-09-27 2021-05-04 雀巢产品有限公司 组氨酸、甘氨酸和其它氨基酸用于预防胰岛素抗性和/或糖尿病的用途
WO2021123245A1 (en) 2019-12-19 2021-06-24 Leibniz-Institut Für Alternsforschung - Fritz-Lipmann-Institut E.V. (Fli) Nad-precursors and dietary restriction for treating age-related medical conditions
AU2020468941A1 (en) * 2020-09-23 2023-03-23 Aminovita S.L. Metabolic cancer therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535049A (en) * 1978-09-04 1980-03-11 Otsuka Pharmaceut Factory Inc Amino acid transfusion for cancerous patient
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
FR2591893B1 (fr) 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US4981687A (en) * 1988-07-29 1991-01-01 University Of Florida Compositions and methods for achieving improved physiological response to exercise
JPH0368514A (ja) * 1989-08-09 1991-03-25 Morishita Pharmaceut Co Ltd 癌用アミノ酸製剤
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
JPH04352720A (ja) * 1991-05-30 1992-12-07 Tanabe Seiyaku Co Ltd 癌患者用アミノ酸製剤
WO1993006834A1 (en) * 1991-10-07 1993-04-15 Otsuka Pharmaceutical Factory, Inc. Enteral preparation for cancer therapy
JP3380287B2 (ja) * 1992-04-07 2003-02-24 麒麟麦酒株式会社 血中アルコール濃度上昇阻害飲料
US6338856B1 (en) * 1998-02-27 2002-01-15 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
JPH11332514A (ja) * 1998-05-22 1999-12-07 Nof Corp バランス栄養食品
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
GB0416493D0 (en) * 2004-07-23 2004-08-25 Pitsiladis Yannis P Hydrating composition
EP1731145A1 (en) * 2005-05-25 2006-12-13 Institut National De La Recherche Agronomique Use of glycerol for improving cardiac function
EP2135604A4 (en) 2007-03-26 2011-08-03 Hirofumi Matsui PREPARATION OF INFUSION FOR PATIENT SUFFERING FROM CANCER

Also Published As

Publication number Publication date
WO2009132320A2 (en) 2009-10-29
JP2011523626A (ja) 2011-08-18
EP2285218B1 (en) 2020-06-17
JP2015186480A (ja) 2015-10-29
CA3045883A1 (en) 2009-10-29
EP2285218A4 (en) 2011-10-05
EP2285218A2 (en) 2011-02-23
CA2722365A1 (en) 2009-10-29
WO2009132320A3 (en) 2010-01-07
CA3045883C (en) 2022-06-28
CA2722365C (en) 2019-08-06

Similar Documents

Publication Publication Date Title
EP2285218B1 (en) Dietary compositions and methods for protection against chemotherapy or radiotherapy
AU2001253919B2 (en) Administration of a thiol-based chemoprotectant compound
JP7434155B2 (ja) オートファジーの誘導のためにオートファジー誘導因子と高タンパク質との組み合わせを使用する組成物及び方法
ES2779749T3 (es) Composiciones que comprenden aminoácidos para uso en el tratamiento de mucositis en pacientes con neoplasia que están sometidos a radioterapia y/o quimioterapia
ES3019570T3 (en) Improved therapeutic index of anti-immune checkpoint inhibitors using combination therapy comprising a phy906 extract or a scutellaria baicalensis georgi (s) extract
US20050197398A1 (en) Therapeutic agent for hepatic disease
AU2018351640A1 (en) Synthetic capsaicin analogues as bioenhancers
Xue et al. Bolus oral glutamine protects rats against CPT-11-induced diarrhea and differentially activates cytoprotective mechanisms in host intestine but not tumor
Chuphal et al. Amino acids as functional nutrients in stress mitigation of aquatic species: mechanisms and applications in aquaculture
CN113905727A (zh) 采用百里酚和/或香芹酚诱发自噬的组合物和方法
KR20100015922A (ko) 암 환자용 수액 제제
ES2981848T3 (es) C-ficocianina para usar en el tratamiento y/o la prevención de la neuropatía periférica
ES2171439T5 (es) Composicion a base de aminoacidos para el tratamiento de infecciones.
ES2308550T3 (es) Formulacion para administracion oral que ejerce un efecto reconstituyente sobre el sistema cardiovascular.
HU227182B1 (en) Lecitin-ascorbic acid combination
AU2017306756B2 (en) Glutamine for preserving, improving or restoring kidney function
CN1826133A (zh) 治疗经化疗的癌症患者的方法
JPH09110686A (ja) マクロファージ一酸化窒素産生亢進剤
WO2010028503A1 (en) Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
Steliou et al. Lactic acid in cancer and mitochondrial disease
Al Shawoush et al. Protective effect of Anodonta cygnea hemolymph against acute kidney injury induced by gentamicin in rats
Perez The use of ozone therapy as adjuvant therapy in cancer: a review of the literature
RU2319498C2 (ru) Биокомпозиция, обладающая антитоксическим и антиапоптозным действием, профилактическая биологическая добавка на ее основе
ES2402477B1 (es) Uso de n-acetilcisteína para proteger a los peces de la intoxicación por cilindrospermopsina.
US20110189312A1 (en) Compositions and Methods for Supporting Heat Shock Protein Function